https://doi.org/10.1136/annrheumdis-2012-202794
L
Laura K. Richman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
142
Papers
4.9K
Citations
32
h-index
49
i10-index
Laura K. Richman is an academic researcher. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research & Viral Infectious Diseases and Gene Expression in Insects. The author has an h-index of 32, co-authored 121 publications.
ORCID: 0000-0001-6155-3619Papers by this author
worksA phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
2013 · Annals of the Rheumatic Diseases · 162 citations
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques
2018 · Molecular Therapy — Methods & Clinical Development · 101 citations
https://doi.org/10.1016/j.omtm.2018.06.003
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques
2018 · Molecular Therapy — Methods & Clinical Development · 81 citations
https://doi.org/10.1016/j.omtm.2018.06.004
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus
2010 · Arthritis Research & Therapy · 78 citations
https://doi.org/10.1186/ar2887
Altered Expression of Insulin Receptor Isoforms in Breast Cancer
2011 · PLoS ONE · 61 citations
https://doi.org/10.1371/journal.pone.0026177
Genomic signatures characterize leukocyte infiltration in myositis muscles
2012 · BMC Medical Genomics · 40 citations
https://doi.org/10.1186/1755-8794-5-53
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat